Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors
- PMID: 2168352
- DOI: 10.1016/0360-3016(90)90534-q
Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors
Abstract
Univariate and multivariate statistical analyses were used to examine the relationships between duration of survival and multiple variables in the presentation and treatment of 82 patients with high-grade gliomas (16 grade 3, 66 grade 4). The median survival time of the eight patients who received less than or equal to 40 Gy to the tumor bed was 16 weeks and was 17 weeks for the three who received between 40 and 50 Gy. Patients who received 50-60 Gy had a median survival time of 62 weeks, compared to 54 weeks in patients who received 60-70 Gy. These differences in median survival time were statistically significant between the extremes (p = 0.0001), as well as between the 40-50 Gy group and the 50-60 Gy group (p = 0.02). However, no significant difference could be detected between the groups receiving 50-60 Gy versus 60-70 Gy. Univariate analysis also identified preoperative performance status, age, histologic grade, extent of surgery, and seizure history as prognostic factors. Cox multivariate analysis was performed to identify variables that were significant in independently predicting duration of survival. Although contemporary studies have shown many variables to be significant in predicting survival, our analysis found that many of them were not independent predictors. The variables which independently predicted improved duration of survival were greater total radiation dose to the tumor bed (p less than 0.0001), superior preoperative performance status (p = 0.003), and grade 3 versus grade 4 (p = 0.04). Younger age at diagnosis was marginally significant (p = 0.07). In the group of 60 patients receiving greater than 50 Gy, a discriminant analysis was also performed. The patients were divided into two groups based on apparent clusters of survival times: greater than or equal to 60 weeks versus less than 60 weeks. The only variable that was found to be predictive of membership in the cluster with longer survival was the presence of seizure activity (p = 0.02). Although univariate and multivariate analyses both showed an apparent statistically significant improvement in survival with increasing total radiation dose to the tumor bed, no additional benefit could be demonstrated for doses greater than 60 Gy.
Similar articles
-
Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.J Neurosurg Sci. 2010 Mar;54(1):7-19. J Neurosurg Sci. 2010. PMID: 20436394
-
Dose-escalated conformal radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses of 60 and 70 Gy.Onkologie. 2005 Jun;28(6-7):325-30. doi: 10.1159/000085574. Epub 2005 Jun 2. Onkologie. 2005. PMID: 15933420
-
Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.Neurosurgery. 2002 Jan;50(1):41-6; discussion 46-7. doi: 10.1097/00006123-200201000-00009. Neurosurgery. 2002. PMID: 11844233
-
Prognostic impact of hemoglobin level prior to radiotherapy on survival in patients with glioblastoma.Strahlenther Onkol. 2003 Sep;179(9):615-9. doi: 10.1007/s00066-003-1097-x. Strahlenther Onkol. 2003. PMID: 14628127
-
[Radiotherapy of glioblastoma].Cancer Radiother. 1997;1(3):194-207. doi: 10.1016/s1278-3218(97)89765-x. Cancer Radiother. 1997. PMID: 9295873 Review. French.
Cited by
-
Postoperative radiotherapy for supratentorial malignant gliomas.J Neurooncol. 1999 Apr;42(2):183-7. doi: 10.1023/a:1006154413957. J Neurooncol. 1999. PMID: 10421077
-
Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy.J Neurooncol. 2009 Jan;91(1):69-81. doi: 10.1007/s11060-008-9685-3. Epub 2008 Sep 23. J Neurooncol. 2009. PMID: 18810326 Free PMC article.
-
The results of hypofractionated radiotherapy in 31 patients with high-grade gliomas.Med Oncol. 2007;24(4):379-83. doi: 10.1007/s12032-007-0030-z. Med Oncol. 2007. PMID: 17917085 Clinical Trial.
-
The conditional survival statistics for survivors with primary supratentorial astrocytic tumors.J Neurooncol. 2000 Dec;50(3):257-64. doi: 10.1023/a:1006484220764. J Neurooncol. 2000. PMID: 11263506
-
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme.Neuro Oncol. 2013 May;15(5):618-25. doi: 10.1093/neuonc/nos338. Epub 2013 Feb 14. Neuro Oncol. 2013. PMID: 23410662 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical